Your lungs harbor a living community of bacteria, fungi, viruses, and other microorganisms that collectively form the lung microbiome. Far from being a passive collection of hitchhikers, these microbial communities influence immune function, shape inflammatory responses, and play measurable roles in diseases ranging from COPD to lung cancer. The lung microbiome is less dense than the gut’s, which has made it harder to study and slower to gain attention, but the past decade of research has fundamentally changed how scientists think about respiratory health.
The End of “Sterile Lungs”
For most of modern medicine, textbooks taught that healthy lungs were sterile. If bacteria showed up in a culture from a patient’s airways, the assumption was infection. That belief persisted for decades without strong evidence behind it. As one review noted, the claim that “the normal lung is free from bacteria” was virtually always stated in textbooks without citation or argument.1PubMed Central. The Microbiome and the Respiratory Tract The problem was partly technological: traditional culture methods, designed to grow pathogens, missed the vast majority of microbes that do not thrive on standard laboratory plates.
The shift came with high-throughput DNA sequencing, which allowed researchers to identify microbes by their genetic material rather than by growing them. These culture-independent techniques revealed that even healthy lower airways contain diverse microbial communities, either transiently passing through or persistently colonizing the tissue.2PubMed Central. The microbiome of the human lower airways: a next generation sequencing perspective The discovery did not just add a footnote to pulmonary medicine. It opened an entirely new way of understanding why some people develop chronic lung disease and others do not.
What Lives in Your Lungs
The lung microbiome includes bacteria, archaea, fungi, protozoa, and viruses.3PubMed Central. The Lung Microbiome: A New Frontier for Lung and Brain Disease Bacteria get the most attention because they are the easiest to detect and the best studied. In a healthy person, the dominant bacterial genera are Streptococcus, Prevotella, Veillonella, Neisseria, and Rothia. These overlap heavily with what you would find in the mouth, which is not a coincidence: the lung microbiome is thought to be seeded primarily from the oral cavity through tiny amounts of saliva that trickle down into the airways during sleep and normal breathing.3PubMed Central. The Lung Microbiome: A New Frontier for Lung and Brain Disease
Beyond bacteria, the lung’s viral community, or virome, is increasingly recognized as a complex ecosystem in its own right. It includes viruses that infect human cells, bacteriophages that target bacteria, and archaeal viruses. Some viral families, like Anelloviridae, appear to be persistent residents rather than disease agents and may function as commensals. A large proportion of viral genetic sequences recovered from the respiratory tract remain unclassified, a phenomenon researchers call “viral dark matter,” hinting that many viral species in the lungs have not yet been described at all.4European Respiratory Review. The respiratory tract virome: unravelling the role of viral dark matter in respiratory health and disease
A Geography of Microbes Inside the Lungs
The lung microbiome is not uniform from one region to the next. Researchers have used an “adapted island model” borrowed from ecology to describe this: the mouth and upper throat act as the mainland source of microbes, and different lung regions behave like islands at varying distances. Consistent with that model, the right upper lobe, which sits closest to the upper airway anatomically, harbors microbial communities that look most like those of the mouth. Farther from the source, community richness decreases.5PubMed Central. Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography
Sampling method matters here too. Researchers collecting fluid that washes over a large surface area of the lung (bronchoalveolar lavage) find higher bacterial burden, greater diversity, and more similarity to the mouth compared to samples taken from a tiny brushed spot deeper in the airways. Measures of mouth-to-lung immigration peak near the carina, the branching point of the main airways, which is what you would expect if micro-aspiration from the throat is the main route microbes take into the lungs.6PubMed Central. Bacterial Topography of the Healthy Human Lower Respiratory Tract This spatial variation has practical consequences: a biopsy or lavage from one lobe may not represent what is happening in another, complicating diagnosis and research alike.
What Keeps the Lung Microbiome in Balance
Unlike the gut, where enormous numbers of bacteria take up permanent residence and reproduce locally, the lung microbiome exists in a much more transient state. In healthy people, the bacteria present in the lungs largely reflect whatever drifted in from the upper airways. Mechanical clearance, through the mucociliary escalator that sweeps particles upward, and immune clearance by resident immune cells, continuously remove microbes. Local bacterial replication in the lungs appears limited.7JCI Insight. The lung microbiome: progress and promise The lung microbiome’s composition at any moment is therefore a snapshot of the balance between immigration from the mouth and throat, elimination by the body’s defenses, and whatever limited growth occurs in place.3PubMed Central. The Lung Microbiome: A New Frontier for Lung and Brain Disease
This balance is fragile. When immigration increases, clearance decreases, or conditions in the lung start favoring certain species over others, such as when inflammation creates a nutrient-rich environment, the community can shift dramatically. That shift, broadly called dysbiosis, is a recurring theme across nearly every chronic and acute lung disease studied so far.
The Gut-Lung Axis
One of the more surprising findings of the past decade is that the gut microbiome influences what happens in the lungs and vice versa. This two-way communication, often called the gut-lung axis, appears to work largely through metabolites and immune signaling. Gut bacteria ferment dietary fiber and produce short-chain fatty acids, which enter the bloodstream and reach the lungs. There, they help regulate immune responses and inflammatory tone.8PubMed. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
Animal and human tissue studies have confirmed that metabolically active gut bacteria transmit both short-chain fatty acids and bacterial components like lipopolysaccharide to the lungs, helping to establish what researchers describe as a baseline immune readiness, or “immune tone.”9PubMed Central. Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids’ immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression When the gut microbiome is disrupted, whether by antibiotics, poor diet, or illness, the downstream effects on lung immunity can be substantial. Dysbiosis in either the gut or the respiratory tract has been linked to immune dysfunction and susceptibility to lung disease.8PubMed. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
The axis also runs in the other direction during critical illness: gut-derived bacteria have been found in the lungs of patients with acute respiratory distress syndrome, suggesting that in severe disease states, bacteria can physically translocate from the intestines to the lungs and contribute to lung injury.10PubMed Central. Composition and diversity of the pulmonary microbiome in acute respiratory distress syndrome: a systematic review
Chronic Lung Disease and Microbial Shifts
Across multiple chronic lung conditions, a common pattern emerges: the diverse, balanced microbiome of a healthy lung gives way to one dominated by fewer species, often including known pathogens. The details differ by disease, but the overall trajectory is strikingly similar.
COPD
In people with chronic obstructive pulmonary disease, the airway microbiome shifts toward a family of bacteria called Proteobacteria, with the genus Haemophilus showing the most pronounced increase. At the same time, bacteria from the Bacteroidetes group, especially Prevotella, decline. This is not a static picture. As lung function worsens, the imbalance deepens: Haemophilus continues to rise while Prevotella and Veillonella continue to fall. Reduced microbial diversity in sputum samples has been connected with more severe airflow limitation.11Respiratory Medicine. Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians
Cystic Fibrosis
The lungs of people with cystic fibrosis tend to be chronically colonized by multiple species that form biofilms, sticky microbial communities that are exceptionally hard for antibiotics to penetrate. Pseudomonas aeruginosa is the most notorious pathogen in this setting, but the airway typically hosts a complex multispecies community that includes Staphylococcus aureus, Streptococcus species, and anaerobic bacteria like Prevotella. Lower microbial diversity in cystic fibrosis airways is associated with worse health outcomes.12PubMed Central. Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm This creates a therapeutic dilemma: aggressive antibiotic courses may eliminate one pathogen but further reduce overall diversity, potentially making the situation worse in the long run.
Idiopathic Pulmonary Fibrosis
In idiopathic pulmonary fibrosis, a progressive scarring disease of the lungs, researchers have found that specific bacterial species correlate with how quickly the disease advances. In one study, higher relative abundance of particular Streptococcus and Staphylococcus strains was significantly associated with disease progression. Patients whose airways had more than about 4% relative abundance of a specific Streptococcus strain and more than about 2% of a Staphylococcus strain had dramatically worse progression-free survival.13PubMed Central. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study Separately, decreased overall microbial diversity predicted worsening lung function and earlier mortality.14PubMed Central. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis Whether the microbiome is actively driving fibrosis or merely reflecting it remains an open question, but the association is strong enough that some researchers see microbiome profiling as a potential prognostic tool.
The Microbiome and Lung Cancer
A growing body of evidence links the lung microbiome to cancer development and progression. Microbial communities appear to influence lung cancer through several routes: by driving chronic inflammation, by altering immune regulation in the tumor microenvironment, and by producing metabolites with genotoxic or metabolic effects.15PubMed Central. The human microbiome: A promising target for lung cancer treatment This does not mean lung microbes directly cause cancer the way a carcinogen does. The relationship is more subtle: a dysbiotic microbiome may create local conditions that favor tumor initiation or allow an established tumor to evade immune surveillance more effectively. Research into whether manipulating the lung or gut microbiome could improve responses to cancer immunotherapy is active but still early-stage.
Critical Illness and Mechanical Ventilation
When patients are placed on mechanical ventilators in intensive care, their lung microbiome undergoes rapid and clinically meaningful changes. Prolonged ventilation, particularly beyond about 72 hours, reduces microbial diversity and promotes a shift toward pathogenic species.16PubMed Central. Impact of Invasive Mechanical Ventilation on the Lung Microbiome One study found that the duration of mechanical ventilation itself, rather than antibiotic use, was the factor most associated with declining microbial diversity. Patients who went on to develop ventilator-associated pneumonia showed a distinct trajectory of microbial community change compared to those who did not, with organisms like Burkholderia and Pseudomonadales rising in prominence.17Thorax. The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia
In acute respiratory distress syndrome, dysbiosis appears to be both a consequence and a contributor to the disease process. Lung inflammation invites pathogenic microbes, whose presence then drives more inflammation, creating a feedback loop. The finding that gut-derived bacteria show up in the lungs of these critically ill patients adds another dimension: the breakdown of the intestinal barrier in severe illness may seed the lungs with organisms that have no business being there.10PubMed Central. Composition and diversity of the pulmonary microbiome in acute respiratory distress syndrome: a systematic review
Smoking and Environmental Disruption
Cigarette smoke is one of the most studied environmental disruptors of the lung microbiome. In both animal models and human patients, smoke exposure triggers dysbiosis that mirrors the microbial patterns seen in advanced COPD. One study found that mice exposed to cigarette smoke developed changes in their lung microbiome, including a rise in Actinobacteriota, along with significant shifts in their intestinal microbiome, confirming that the effects of smoking extend beyond the lungs. The dysbiosis patterns in smoke-exposed mice closely resembled those seen in patients with the most severe stage of COPD, suggesting that smoke-driven microbial disruption may be an early step in disease progression rather than just a late consequence.18PubMed Central. Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients Correlations between lung function measures and the degree of microbial disruption were observed in both the lung and intestinal microbiomes, reinforcing the idea that the gut-lung axis is a genuine conduit for systemic damage from smoking.
How Age Shapes the Lung Microbiome
The lung microbiome is not fixed from birth. In animal studies, lungs begin with low microbial diversity that increases steadily with age, and the early-life microbial community is highly susceptible to even minor environmental changes. In contrast, the adult lung microbiome shows more resilience to environmental variation.19PubMed. Development of a Stable Lung Microbiome in Healthy Neonatal Mice This stabilization with age has implications for childhood respiratory health: disruptions to the developing lung microbiome, whether from early antibiotic use, environmental exposures, or mode of birth, may have outsized effects compared to similar disruptions in adulthood.
At the other end of life, aging brings its own shifts. A study comparing respiratory microbiome profiles in young and elderly adults found that while the same core genera (Streptococcus, Prevotella, Neisseria, Rothia, and Veillonella) were present in both groups, older individuals showed higher ratios of certain Firmicutes bacteria relative to Proteobacteria. Specific genera like Veillonella and Megasphaera increased, while Haemophilus and several other Proteobacteria decreased.20European Respiratory Journal. Age-associated change in respiratory microbiome architecture in healthy Singaporean subjects Whether these age-related shifts contribute to the increased respiratory vulnerability of older adults is still being investigated.
The Challenge of Studying a Low-Biomass Ecosystem
Everything discussed above comes with an important caveat: the lung microbiome is one of the most technically difficult ecosystems to study in the human body. Compared to the gut, which teems with bacteria, the lungs have a very low microbial density. This creates a signal-to-noise problem that researchers constantly wrestle with. When you are trying to detect tiny amounts of microbial DNA in a sample, contamination from reagents, lab equipment, and the sample collection process itself can dominate the results.
Bronchoalveolar lavage, the gold standard for sampling the lower lung microbiome, commonly yields samples with such low bacterial density that false-positive signals from contaminating DNA become a real risk.21PubMed Central. Microbiota analysis optimization for human bronchoalveolar lavage fluid One investigation estimated that roughly 10 to 50 percent of the bacterial community profiles in lower airway samples could be traced to contaminating DNA introduced during laboratory processing, with the DNA extraction kit identified as the main source.22PubMed Central. Laboratory contamination in airway microbiome studies This does not mean the lung microbiome findings are unreliable, but it does mean that studies vary in quality depending on how rigorously they control for contamination. Readers encountering dramatic claims about the lung microbiome should look for whether the study included proper negative controls and contamination filtering.
Therapeutic Frontiers
If the lung microbiome influences health so broadly, the natural next question is whether you can intervene. Probiotics taken orally already have some evidence of protective effects against lung diseases, possibly mediated through the gut-lung axis. More adventurously, researchers have begun exploring whether delivering live bacteria directly to the lungs, via nasal or intratracheal routes, could modulate respiratory disease. Early studies show promise in animal models, with inhaled probiotics demonstrating the ability to shift lung microbial communities and reduce markers of disease.23PubMed Central. Lung Microbiota: Its Relationship to Respiratory System Diseases and Approaches for Lung-Targeted Probiotic Bacteria Delivery
The practical obstacles are significant. Delivering living bacteria to the lungs in a controlled, reproducible way requires formulation technology that barely exists yet. The bacteria need to survive aerosolization, reach the right lung regions, and interact productively with the existing community and immune system without triggering harm. Studies on pulmonary delivery of probiotics remain very few, and none have reached the stage of large human trials. Still, the conceptual framework is in place: if dysbiosis contributes to disease, then restoring a healthy microbial balance, whether through the gut, the airways, or both, is a logical therapeutic strategy. Whether that strategy will work as cleanly in humans as it does in mice is the question the next decade of research needs to answer.